Skip to content
Recompete RadarPUBLIC SECTOR INTELLIGENCE
Recompete Brief

NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets

Priority 100/100Engage now
BuyerNHS England
Current supplierMerck Sharpe & Dohme (UK) Limited
Published value£8,545,000
Expiry31 Oct 2027
Recommended move
Engage now
Start buyer research and early engagement now.
Priority 100/100 · Evidence completeness 87/100

Why this opportunity deserves a look

✓362 days to recorded expiry
✓20 previous procurements found
✓30 historical suppliers found